glp-1 obesity drug news today 2025 Retatrutide, the next generation of from Eli Lilly, helped participants lose an average of 71.2 pounds and reduce knee arthritis pain in a late-stage clinical trial, the company announced. In WHO Decision Recognizing Obesity as
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1








:max_bytes(150000):strip_icc()/VWH-GettyImages-2177964629-9f7413a5ef1b43cc9ba7cbdc67275974.jpg)


















